BGM Group Ltd
bgmgroupltd.comWhat Do They Do?
Sells medicines, pharmaceutical ingredients and herbal products to distributors, dealers and corporate customers. Also provides customized AI software solutions to enterprises and operates an insurance business.
How Do They Make Money?
For pharmaceutical products, customers buy at fixed prices set in sales orders and invoices, and sales are counted when customers accept the goods, generally at delivery. AI Solutions also sells products, with sales counted when customers accept them.
20-F for FY2025, filed Jul 21, 2026The Company enters into contracts with customers for from the sales of Diversified Pharma & Allied Portfolio. Each contract is assessed at…View ↗
The majority of the WFOE, the VIEs and VIEs’s subsidiaries’ contracts have one single performance obligation as the promise to transfer the…View ↗
AI solutions offer enterprises customized AI software services and solutions to sell products. The Company generates revenue from the sale…View ↗
$37.9M
-
20-F for FY2025, filed Jul 21, 2026
$37.9M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
International markets
|
0.0% |
International markets, FY2025
$0 Sources
|
|
|
Diversified Pharmaceutical and Allied Products
Sold outright
20-F for FY2025, filed Jul 21, 2026 |
62% |
Diversified Pharmaceutical and Allied Products, FY2025
$23.6M Sources
|
Sold outright |
|
AI Solutions
Sold outright
|
8.9% |
AI Solutions, FY2025
$3.4M Sources
|
Sold outright |
|
Insurance Business
|
29% |
Insurance Business, FY2025
$11M Sources
|
Who Are Their Customers?
The company sells through qualified distributors and dealers and also sells to corporate customers across China.
20-F for FY2025, filed Jul 21, 2026
20-F for FY2025, filed Jul 21, 2026
Do Revenues Turn Into Profits?
No. It lost $19.9M in FY2025.
20-F for FY2025, filed Jul 21, 2026
−$12.6MView ↗
20-F for FY2025, filed Jul 21, 2026
−$19.9MView ↗
20-F for FY2025, filed Jul 21, 2026
−$3.9MView ↗
How Are They Changing?
Shrinking. Revenue fell 34% in 4 years, from $57.1M in FY2021 to $37.9M in FY2025, about 10% a year.
Who Do They Compete With?
Competes with Jiangxi Pharmaceutical, Shanxi Datong Tongxing Antibiotics, Chifeng Pharmaceutical, Hebei Shengxue Dacheng Pharmaceutical, Yunnan Baiyao Group, Kunming Pharmaceutical Group, Hunan Jianlang Pharmaceutical, Hainan Pharmaceutical Factory, Anhui Fengyuan Pharmaceutical, Baoji Jinsen Pharmaceutical, Xinjiang Tarim Agricultural Comprehensive Development, Jiangxi Jin Furong Pharmaceutical, Fuzhou Haiwang Jinxiang Chinese Medicine Pharmaceutical, Xinjiang Sinopharm Group, Gansu Shikefeng New Fertilizer, Beijing Century Arms Biotechnology, Ningxia Yipin Biotechnology, Shijiazhuang Golden Sun Bio-organic Fertilizer, Ningxia Beite Fertilizer, and Gansu Jinhua Group
20-F for FY2025, filed Jul 21, 2026 Products Competitors Compound Licorice Tablets (a pharmaceutical product that has similar medical efficacy compared to the…View ↗
Loading...
